Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

ClinicalTrials.gov ID: NCT05172726

Public ClinicalTrials.gov record NCT05172726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 11:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Study of Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open-label, multi-center, Phase 3 study to evaluate tapinarof cream, 1% in pediatric subjects with plaque psoriasis.

Study identification

NCT ID
NCT05172726
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Organon and Co
Industry
Enrollment
58 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2, 2021 (Actual)
Primary completion
Oct 2026 (Estimated)
Completion
Oct 2026 (Estimated)
Last update posted
Apr 17, 2026

2021 – 2026

United States locations

U.S. sites
12
U.S. states
8
U.S. cities
11
Facility City State ZIP Site status
Northwest Arkansas Clinical Trials Center, PLLC Rogers Arkansas 72758 —
First OC Dermatology Fountain Valley California 92708 —
Mission Dermatology Center Rancho Santa Margarita California 92688 —
RM Medical Research Miami Lakes Florida 33014 —
San Marcus Research Clinic, Inc. Miami Lakes Florida 33014 —
Olympian Clinical Research Tampa Florida 33615 —
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 —
Dawes Fretzin Clinical Research Group Indianapolis Indiana 46250 —
Options Research Group West Lafayette Indiana 47906 —
Wright State Physicians Pharmacology Translational Unit Fairborn Ohio 45324 —
Oregon Dermatology & Research Center Portland Oregon 97210 —
Dermatology Specialists of Spokane Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05172726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2026 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05172726 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →